Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8903 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD230 |
Phase 1 |
0.8543 |
High Similarity |
NPD6190 |
Approved |
0.8494 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8485 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8424 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8415 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.84 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8373 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8364 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8323 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8261 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8166 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8153 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8072 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7963 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7901 |
Intermediate Similarity |
NPD37 |
Approved |
0.7901 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7888 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7866 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7866 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7866 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7853 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7738 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7719 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7679 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7651 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7625 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD8313 |
Approved |
0.76 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7598 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7553 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD943 |
Approved |
0.7531 |
Intermediate Similarity |
NPD1512 |
Approved |
0.753 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7486 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7425 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7381 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7378 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7365 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7321 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7312 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7308 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7301 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7278 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7258 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD5401 |
Approved |
0.725 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7228 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7228 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7225 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7208 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7205 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7196 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7193 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7186 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7182 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7158 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7125 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7112 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7112 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7072 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7048 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7044 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7026 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7026 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7 |
Intermediate Similarity |
NPD6386 |
Approved |
0.6989 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6989 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6982 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD1240 |
Approved |
0.6979 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6979 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6975 |
Remote Similarity |
NPD2796 |
Approved |
0.6974 |
Remote Similarity |
NPD7874 |
Approved |
0.6974 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7585 |
Approved |
0.6948 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD447 |
Suspended |
0.6927 |
Remote Similarity |
NPD7698 |
Approved |
0.6927 |
Remote Similarity |
NPD7697 |
Approved |
0.6927 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6918 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD3748 |
Approved |
0.6914 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6907 |
Remote Similarity |
NPD7583 |
Approved |
0.6906 |
Remote Similarity |
NPD7039 |
Approved |
0.6906 |
Remote Similarity |
NPD7038 |
Approved |
0.6894 |
Remote Similarity |
NPD1607 |
Approved |
0.6875 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6872 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD5406 |
Approved |
0.6871 |
Remote Similarity |
NPD5404 |
Approved |
0.6871 |
Remote Similarity |
NPD5408 |
Approved |
0.6871 |
Remote Similarity |
NPD5405 |
Approved |
0.6852 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD7584 |
Approved |
0.6818 |
Remote Similarity |
NPD1091 |
Approved |
0.6811 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6807 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6789 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.678 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6768 |
Remote Similarity |
NPD7801 |
Approved |
0.6761 |
Remote Similarity |
NPD919 |
Approved |
0.675 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6747 |
Remote Similarity |
NPD6674 |
Discontinued |
0.673 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6716 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6712 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6706 |
Remote Similarity |
NPD6273 |
Approved |
0.6705 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6687 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6686 |
Remote Similarity |
NPD3226 |
Approved |
0.6684 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6648 |
Remote Similarity |
NPD5711 |
Approved |
0.6648 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6648 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6648 |
Remote Similarity |
NPD5710 |
Approved |
0.6647 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6646 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6646 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD1203 |
Approved |
0.6645 |
Remote Similarity |
NPD9493 |
Approved |
0.6627 |
Remote Similarity |
NPD7440 |
Discontinued |
0.6609 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6595 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6593 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6592 |
Remote Similarity |
NPD1247 |
Approved |
0.6582 |
Remote Similarity |
NPD3225 |
Approved |
0.657 |
Remote Similarity |
NPD920 |
Approved |
0.6566 |
Remote Similarity |
NPD6099 |
Approved |
0.6566 |
Remote Similarity |
NPD6100 |
Approved |
0.6564 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6561
|
Remote Similarity |
NPD1608 |
Approved |